Blood filtering trial offers new hope for type 1 diabetes control
NCT ID NCT05413005
Summary
This small pilot study is testing whether a blood filtering treatment called extracorporeal photopheresis (ECP) can help people with type 1 diabetes better control their condition. Ten adults with recent type 1 diabetes diagnosis will receive either a regular or accelerated schedule of ECP treatments along with their standard diabetes care. Researchers will check if the treatment is safe and if it helps reduce insulin needs and improve blood sugar control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abu Dhabi Stem Cells Center
Abu Dhabi, Abu Dhabi Emirate, 4600, United Arab Emirates
Conditions
Explore the condition pages connected to this study.